Borrayo-Sánchez G, Sosa-Jarero F, Borja-Terán B, Isordia-Salas I, Argüero-Sánchez R

Language: Spanish
References: 16
Page: 231-235
PDF size: 84.57 Kb.

ABSTRACT

Objective: We measured the diagnostic value of troponin I (TnI), mioglobin (Miog) and creatine kinase MB (CPK-MB) in patients with thoracic pain during the period of preadmission to the hospital.
Methods: We included patients who requested prehospital attention with intensive therapy ambulance or who were in the first hours of hospitalization for thoracic pain. A 12-lead electrocardiogram was carried out in the ambulance or in the emergency room. The levels of total creatine phosphokinase were determined (as reference pattern). Five study groups were included: group I, 13 patients with acute myocardial infarction without elevation of the ST segment; group II, 11 patients with unstable angina; group III, 14 patients with atypical thoracic pain for angina; group IV, five healthy patients; and group V, five patients with acute myocardial infarction with elevation of the ST segment. A qualitative evaluation was made with an automatic device for quick interpretation of TnI, Miog and CPK-MB.
Results: Forty eight patients were studied with an average age of 55 ± 18 years, 25 men (52%) and 23 women (48%), average time of symptom evolution was 3.5 h (quartiles 2 and 6 h). Total level of CPK was taken as a reference pattern. Sensitivity of TnI, Miog, and CPK-MB was 100%, specificity was 94, 91 and 94%, respectively. Positive predictive value was 89, 84 and 89%, respectively. Negative predictive value was 100%. Likelihood of probability was 8.7, 5.5 and 8.7, respectively.
Conclusions: TnI, Miog and CPK-MB have high diagnostic value in acute coronary syndrome (ACS) from the time of prehospital admission. Determination is advisable as part of the diagnostic protocol, which is of great importance in order to plan the hospitalization and treatment in this group of patients.

REFERENCES

1. 1.Dirección General de Estadística e Informática. Estadísticas vitales, daños a la salud y mortalidad. México: Secretaría de Salud; 2002.

2. 2.American Heart Association. Heart Disease and Stroke Statistics-2004 Update, Dallas, TX: American Heart Assocciation;2003.

3. 3.Fox KF, Cowie MR, Word RA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001;22:228-286.

4. 4.Edmondstone WM. Cardiac chest pain: does body language help the diagnosis? BMJ 1995;311:1660-1661.

5. 5.Brady WJ, Syrverud SA, Beagle C, et al. Electrocardiographic STsegment elevation. Acad Emerg Med 2001;8:961-967.

6. 6.The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial Infarction Redefined—A Consensus Document of The Join European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. JACC 2000;36:959-969.

7. 7.Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST-segment elevation. Recommendation of the Task Force of the European Society of Cardiology. Eur Heart J 2002;23:1809-1840.

8. 8.Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol 2002;40:1366-1374.

9. 9.Norgaard BL, Andersen K, Thygesen K, et al. Long-term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart 2004;90:739-744.

10. 10.Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-1653.

11. 11.Green GB, Beaudreau RW, Chan DW, et al. Use of troponin T and creatine kinase-MB subunit levels for risk stratification of emergency department patients with possible myocardial ischemia. Am Emerg Med 1998;31:19-29.

12. 12.Jernberg T, Lindahl B, James S, et al. Comparison between strategies using creatine kinase-MB (mass), myoglobin and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. Am J Cardiol 2000;86:1367-1371.

13. 13.Kemp M, Donovan J, Hooper J. Biochemical markers of myocardial injury. Br J Anaesth 2004;93:63-73.

14. 14.Selker HP, Beshansky JR, Griffith JL, et al. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute ischemia: a multicenter, controlled clinical trial. Ann Intern Med 1998;129:845-855.

15. 15.Caragher TE, Fernandez BB, Jacobs FL, et al. Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. J Emerg Med 2002;22:1-7.

16. 16.Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. The Lancet 1994;343:311-322.